A Study To Determine The Effect Of SB-480848 On Asthma
NCT00368576
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class
Conditions
Atherosclerosis
Interventions
DRUG:
SB 480848, tablets
Sponsor
GlaxoSmithKline